Supplementary information Supplementary Tables 14 Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
In clinical trials, Mounjaro helped patients lose 22.5% of their starting weight on average, while Ozempic (Wegovy) helped people lose around 21%
Regular follow-up with your provider ensures that dosing remains appropriate and that any emerging concerns are addressed promptly
The effects on kidney and CV events with finerenone treatment compared with placebo in the FIDELITY analysis were similar in 944 users of GLP-1RAs at baseline and in 12,082 nonusers of GLP-1RAs, with no significant interaction, thus supporting their combined use (24)
A body managing a significant energy deficit has less spare metabolic capacity for repair between sessions